Renovacor
Latest round
- Series A
Last raised
- Aug 2019
Total raised
- $11M
Investors
- 5
About Renovacor
Founded in 2013 and headquartered in Greenwich, US, Renovacor, Inc. specializes in gene therapies targeting cardiovascular conditions. The firm was acquired by Rocket Pharmaceuticals, Inc. for USD 53 mn in stocks on September 21, 2022, to enhance their cardiology focus. The company has completed a total of 4 deals since its inception.Renovacor, Inc. primarily develops gene therapies aimed at treating various cardiovascular diseases.Renovacor, Inc.Renovacor, Inc. is strategically positioned for growth by focusing on the development of new gene therapy products targeting cardiovascular diseases, with plans to introduce these therapies in the next few years. The company aims to expand into international markets, particularly in Europe and Asia. will be utilized to enhance research capabilities and accelerate the development of key therapeutic assets.
Who invested in Renovacor
5 investors across 1 round
See all investors in Renovacor
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 12, 2019
Amount
$11M
Investors
Questions about Renovacor
Who invested in Renovacor?
Renovacor has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Renovacor raised?
Renovacor has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Renovacor last raise money?
Renovacor's most recent round on record is a Series A, in Aug 2019.
What does Renovacor do?
Founded in 2013 and headquartered in Greenwich, US, Renovacor, Inc.
Where is Renovacor headquartered?
Renovacor is headquartered in Greenwich, US.
Which VCs invest in companies like Renovacor?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Renovacor's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Renovacor? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.